⬆️🇺🇸 Moderna’s shares surged to an all-time high, climbing 177% — the largest gain among all stocks in the S&P 500. This record run follows the company’s announcement of successful Phase 3 clinical trials for its skin cancer vaccine, marking a major breakthrough in immunotherapy research. The results position Moderna at the forefront of cancer treatment innovation, extending its impact beyond mRNA vaccines. Investors responded strongly, fueling the stock’s historic rise.
#BiotechBreakthrough #SkinCancer #Moderna #mRNA #ClinicalTrials
Learn more about the trial
Crypto News
1August 20, 2026 27
